Medtronic plc (MDT)

Medtronic plc develops, manufactures, and sells device-based medical therapies to healthcare systems, physicians, clinicians, and patients in the United States, Ireland, and internationally. It operates through three segments: The Cardiovascular Portfolio, Neuroscience Portfolio, and Medical Surgical Portfolio. The Cardiovascular Portfolio segment offers implantable cardiac pacemakers, cardioverter defibrillators, and cardiac resynchronization therapy devices; cardiac ablation products; insertable cardiac monitor systems; TYRX products; and remote monitoring and patient-centered software. It also provides aortic valves, surgical valve replacement and repair products, endovascular stent grafts and accessories, and transcatheter pulmonary valves, left atrial appendage exclusion systems, extracorporeal membrane oxygenation (ECMO) systems and percutaneous coronary intervention products, percutaneous angioplasty balloons, and endovenous products. The Neuroscience Portfolio segment offers medical devices and implants, biologic solutions, spinal cord stimulation and brain modulation systems, implantable drug infusion systems, and interventional products, as well as nerve ablation system under the Accurian name. This segment offers its products for spinal surgeons, neurosurgeons, neurologists, pain management specialists, anesthesiologists, orthopedic surgeons, urologists, urogynecologists, and interventional radiologists, as well as ear, nose, and throat specialists, and energy surgical instruments. The Medical Surgical Portfolio segment offers surgical stapling devices, vessel sealing instruments, wound closure and electrosurgery products, AI-powered surgical video and analytics platform, robotic-assisted surgery products, hernia mechanical devices, mesh implants, gynecology products, gastrointestinal and hepatologic diagnostics and therapies, and therapies to treat diseases and conditions, and patient monitoring and airway management products, as well as insulin pumps and consumables, continuous glucose monitoring systems, and sensors. Medtronic plc was founded in 1949 and is headquartered in Galway, Ireland.

Symbol
MDT
Exchange
NYSE
Sector
Healthcare
Industry
Medical Devices
Market cap
$110.57B
52 week range
73.31 - 106.33

Valuation

Share price
$86.38 (close of 2026-10-02)
P/E (TTM)
21.12x
Price to book
2.17x
Price to free cash flow
18.03x
Enterprise value
$129.90B
Book value per share
$39.73

Price performance

PeriodChange
1 day-0.07%
5 days-2.55%
1 month-6.29%
3 months+3.83%
6 months-0.29%
Year to date-10.08%
1 year-9.53%
3 years+11.07%
5 years-32.15%
10 years-0.02%
All time+24580.00%

Members of Congress who disclosed MDT trades

Julie Johnson · Richard McCormick · Robert Bresnahan · Bruce Westerman · Kevin Hern · Alan Armstrong · Emily Randall · George Whitesides · Gilbert Ray Cisneros · Jefferson Shreve · Tommy Tuberville

Super investors holding MDT

First Eagle Investment (First Eagle Investment Management, LLC) · Dodge & Cox (Dodge & Cox Funds) · Ken Griffin (Citadel) · Richard Pzena (Pzena Investment Management) · Harry Burn (Sound Shore Management) · Ray Dalio (Bridgewater Associates) · David Katz (Matrix Asset Advisors Inc) · Mairs & Power (Mairs & Power Inc) · Robert Olstein (Olstein Capital Management) · Hillman Capital (Hillman Capital Management, Inc)

Profitability and growth

Return on equity
9.59%
Return on invested capital
7.51%
Return on assets
5.16%
Return on capital employed
7.95%
Gross margin
65.02%
Net margin
13.20%
EBITDA margin
25.92%
Revenue growth
8.43%
Net income growth
2.98%
Free cash flow growth
4.65%

Cash flow and balance sheet

Free cash flow yield (TTM)
5.55%
Current ratio
2.07x
Net debt to EBITDA
1.88x

Latest reported year

Period end
2026-04-24
Fiscal year
2026
Revenue
$36.36B
Cost of revenue
$12.72B
Gross profit
$23.64B
EBITDA
$9.43B
Net income
$4.80B
Earnings per share
$3.75
Shares outstanding
1.28B

Income statement by year

Period endRevenueGross profitNet incomeEPS
2026-04-24$36.36B$23.64B$4.80B$3.75
2025-04-25$33.54B$21.91B$4.66B$3.63
2024-04-26$32.36B$21.15B$3.68B$2.77
2023-04-28$31.23B$20.51B$3.76B$2.83
2022-04-29$31.69B$21.54B$5.04B$3.75
2021-04-30$30.12B$19.63B$3.61B$2.68
2020-04-24$28.91B$19.49B$4.79B$3.57
2019-04-26$30.56B$21.40B$4.63B$3.44
2018-04-27$29.95B$20.90B$3.10B$2.29
2017-04-28$29.71B$20.42B$4.03B$2.92

Margins and returns by year

Period endGross marginNet marginReturn on equityReturn on capital
2026-04-2465.02%13.20%9.59%7.51%
2025-04-2565.32%13.90%9.66%7.40%
2024-04-2665.34%11.36%7.29%5.95%
2023-04-2865.67%12.03%7.27%5.74%
2022-04-2967.98%15.90%9.56%11.31%
2021-04-3065.19%11.97%6.99%10.07%
2020-04-2467.41%16.56%9.41%7.28%
2019-04-2670.04%15.16%9.22%8.57%
2018-04-2769.77%10.36%6.11%6.21%
2017-04-2868.73%13.56%8.00%6.86%

Cash and debt by year

Period endCashDebt
2026-04-24$9.22B-
2025-04-25$8.96B-
2024-04-26$8.01B-
2023-04-28$7.96B-
2022-04-29$10.57B-
2021-04-30$10.82B-
2020-04-24$10.95B$22.14B
2019-04-26$9.85B$24.55B
2018-04-27$11.23B$23.69B
2017-04-28$13.71B$25.87B

Free cash flow by year

Period endFree cash flowStock-based compensation
2026-04-24$5.43B$457.00M
2025-04-25$5.18B$429.00M
2024-04-26$5.20B$393.00M
2023-04-28$4.58B$355.00M
2022-04-29$5.98B$359.00M
2021-04-30$4.88B$344.00M
2020-04-24$6.02B$297.00M
2019-04-26$5.87B$290.00M
2018-04-27$3.62B$344.00M
2017-04-28$5.63B$348.00M

Dividend history

Most recent payment
2026-09-25
Paid in the last twelve months
$2.86
Payment dateDividend per share
2026-09-25$0.72
2026-06-26$0.72
2026-03-27$0.71
2025-12-26$0.71
2025-09-26$0.71
2025-06-27$0.71
2025-03-28$0.70
2024-12-27$0.70

Investor relations

Next earnings report

Next confirmed report
2026-11-17
Consensus EPS estimate
$1.34

Past earnings dates

ReportedFiscal periodEPS estimate
2026-09-01Jul/2026$1.38
2026-06-03Apr/2026$1.54
2026-02-17Jan/2026$1.33
2025-11-18Oct/2025$1.31
2025-08-19Jul/2025$1.23
2025-05-21Apr/2025$1.58
2025-02-18Jan/2025$1.36
2024-11-19Oct/2024$1.24

Filings and sources

Company website
medtronic.com
SEC filings
10-K, 10-Q and 8-K on EDGAR
Earnings calendar
All upcoming reports

Similar companies

Stryker Corp (SYK) · Abbott Laboratories (ABT) · Boston Scientific Corp (BSX) · Edwards Lifesciences Corp (EW) · Dexcom Inc (DXCM) · Universal Health Services Inc (UHS) · DaVita Inc. (DVA) · HCA Healthcare, Inc. (HCA)

All Healthcare companies

Understanding these figures

Price-to-earnings ratio · Discounted cash flow · Free cash flow · Earnings per share · Return on equity · Gross margin vs net margin · Reading a balance sheet · Debt and leverage · Dividend yield · Insider transactions and Form 4 · How to read a stock chart

Explore

Company directory · S&P 500 heatmap · Earnings calendar · Super investor holdings · Congress trades